Prevalence of Micronutrient Deficiencies and Relationship with Clinical and Patient-Related Outcomes in Pulmonary Hypertension Types I and IV
Authors:
- Paulien VinkePVPaulien Vinke
- Thomas KoudstaalTKThomas Koudstaal
- Femke MuskensFMFemke Muskens
- Annemien van Den BoschABAnnemien van Den Bosch
- Michiel BalversMBMichiel Balvers
- Mieke PolandMPMieke Poland
- Renger F. WitkampRWRenger F. Witkamp
- Klaske van NorrenKNKlaske van Norren
- Karin A. BoomarsKBKarin A. Boomars
Open Access
Abstract
Background: Pulmonary hypertension (PH) is a rare progressive and lethal disease affecting pulmonary arteries and heart function. The disease may compromise the nutritional status of the patient, which impairs their physical performance. This study aimed to determine the prevalence of micronutrient deficiencies in pulmonary arterial hypertension (PAH) and chronic thrombo-embolic pulmonary hypertension (CTEPH) patients. Methods: Eighty-one blood samples from a prospective observational cohort study were analyzed for concentrations of micronutrients and inflammation-related factors. The samples consisted of newly diagnosed (treatment-naive) PAH and CTEPH patients and patients treated for 1.5 years according to ERS/ESC guidelines. Results: In the newly diagnosed group, 42% of PAH patients and 21% of CTEPH patients were iron deficient compared to 29% of PAH patients and 20% of CTEPH patients in the treatment group. Vitamin D deficiency occurred in 42% of the newly diagnosed PAH patients, 71% of the newly diagnosed CTEPH patients, 68% of the treated PAH patients, and 70% of the treated CTEPH patients. Iron levels correlated with the 6 min walking distance (6MWD). Conclusions: Iron and vitamin D deficiencies are highly prevalent in PAH and CTEPH patients, underlining the need for monitoring their status. Studies evaluating the effects of supplementation strategies for iron and vitamin D are necessary.Keywords
Funding Information
- Actelion Pharmaceuticals (N/A, N/A)
This publication has 46 references indexed in Scilit:
- Vitamin D Metabolism, Mechanism of Action, and Clinical ApplicationsChemistry & Biology, 2014
- 25-Hydroxyvitamin D Response to Graded Vitamin D3Supplementation Among Obese AdultsThe Journal of Clinical Endocrinology & Metabolism, 2013
- Definitions and Diagnosis of Pulmonary HypertensionJACC, 2013
- Vitamin D: a negative acute phase reactantJournal of Clinical Pathology, 2013
- An Evaluation of Long-term Survival From Time of Diagnosis in Pulmonary Arterial Hypertension From the REVEAL RegistryChest, 2012
- Iron deficiency in pulmonary arterial hypertension: a potential therapeutic targetEuropean Respiratory Journal, 2011
- Unexplained iron deficiency in idiopathic and heritable pulmonary arterial hypertensionThorax, 2011
- Iron deficiency is common in idiopathic pulmonary arterial hypertensionEuropean Respiratory Journal, 2010
- Abnormal mitochondrial function in locomotor and respiratory muscles of COPD patientsEuropean Respiratory Journal, 2009
- Vitamin D in preventive medicine: are we ignoring the evidence?British Journal of Nutrition, 2003